Furthermore, for the first time, it was found that the addition of sclareol to cyclophosphamide treatment increased the potency of this anti-cancer agent via the induction of apoptotic cell death as well as inhibition of STAT3 phosphorylation. The gene discussed is STAT3; the disease is cancer.